ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,327Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 434

$1.34M Total Retail Price of All Prescriptions

Rank: 4 out of 434

841 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 841 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 841 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 23,165 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
HYDROCODONE-ACETAMINOPHEN 1,064 763 S3 1 4
LISINOPRIL 1,048 856 2 1
LEVOTHYROXINE SODIUM 931 751 3 3
AMLODIPINE BESYLATE 880 615 4 6
SIMVASTATIN 857 757 5 2
WARFARIN SODIUM 802 673 6 18
FUROSEMIDE 779 655 7 9
OMEPRAZOLE 729 610 8 5
METOPROLOL TARTRATE 690 507 9 12
METFORMIN HCL 679 517 10 7
NAMENDA 569 568 11 72
ALENDRONATE SODIUM 557 490 12 15
POTASSIUM CHLORIDE 490 425 13 20
DONEPEZIL HCL 483 483 14 35
RISPERIDONE 415 329 15 87
ALBUTEROL SULFATE 359 273 16 143
HYDROCHLOROTHIAZIDE 325 237 17 8
MIRTAZAPINE 312 304 18 97
CARVEDILOL 308 300 19 24
GABAPENTIN 308 159 19 14
CLOPIDOGREL 296 263 21 41
NOVOFINE AUTOCOVER 293 256 10 22 148
RANITIDINE HCL 293 219 22 31
LEVEMIR FLEXPEN 266 236 24 139
GLIPIZIDE 261 213 25 37
ATENOLOL 258 206 26 16
FENTANYL 252 162 S2 27 135
QUETIAPINE FUMARATE 246 170 28 128
ALLOPURINOL 237 190 29 25
IPRATROPIUM BROMIDE 232 180 30 168
CITALOPRAM HBR 231 189 31 23
LOSARTAN POTASSIUM 226 197 32 13
DIVALPROEX SODIUM 220 217 33 111
CARISOPRODOL 219 92 R 34 44
FAMOTIDINE 211 170 35 76
MORPHINE SULFATE ER 206 70 S2 36 50
OXYCODONE-ACETAMINOPHEN 205 54 S2 37 74
HYDRALAZINE HCL 200 134 38 79
TAMSULOSIN HCL 197 180 39 29
PLAVIX 196 178 40 64
DIGOXIN 191 155 41 69
CILOSTAZOL 186 169 42 177
ISOSORBIDE MONONITRATE ER 173 144 43 68
NOVOLOG FLEXPEN 159 139 44 138
AZITHROMYCIN 159 116 44 38
PANTOPRAZOLE SODIUM 157 124 46 66
AMIODARONE HCL 155 116 47 153
ATORVASTATIN CALCIUM 150 113 48 19
LOVASTATIN 142 135 49 10
LEVETIRACETAM 140 82 50 152
SERTRALINE HCL 139 110 51 27
GEMFIBROZIL 139 76 51 62
ZOLPIDEM TARTRATE 138 27 53 11
OXYCODONE HCL-ACETAMINOPHEN 136 63 S2 54 53
MUPIROCIN 136 111 54 174
LOVAZA 135 45 56 107
NIFEDIPINE ER 135 115 56 86
OXYCODONE HCL 134 29 S2 58 34
CLONIDINE HCL 132 88 59 63
SODIUM CHLORIDE 130 92 60 172
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 87 61 21
CARBIDOPA-LEVODOPA 123 115 62 154
DIOVAN 118 82 63 105
PRAVASTATIN SODIUM 118 92 63 17
JANUVIA 116 110 65 115
PREVACID 115 87 66 213
TERAZOSIN HCL 109 97 67 40
TRAZODONE HCL 108 68 68 33
ACETAMINOPHEN-CODEINE 108 92 S3 68 117
INSULIN SYRINGE 103 78 70 120
ABILIFY 103 86 70 224
VENTOLIN HFA 102 61 72 30
CIPROFLOXACIN HCL 102 85 72 55
VERAPAMIL ER 101 95 74 78
TRAMADOL HCL 99 58 75 28
SEROQUEL 97 71 76 229
POLYETHYLENE GLYCOL 3350 97 82 76 81
LEVOFLOXACIN 91 76 78 131
PAROXETINE HCL 91 37 78 61
NOVOLOG 91 78 78 233
PROAIR HFA 90 50 81 60
TRIAMCINOLONE ACETONIDE 89 70 82 94
FLUOXETINE HCL 89 76 82 32
NEXIUM 88 43 84 95
METOPROLOL SUCCINATE 86 71 85 22
LIDODERM 86 73 85 171
PHENYTOIN SODIUM EXTENDED 85 38 87 163
SPIRIVA 84 69 88 36
LANTUS 84 42 88 80
EXELON 83 83 90 238
GLYBURIDE 82 59 R 91 51
METOCLOPRAMIDE HCL 80 31 92 205
BUDESONIDE 79 44 93 241
PRADAXA 79 79 93 241
CLOTRIMAZOLE-BETAMETHASONE 78 54 95 124
PHENYTOIN 76 54 96 245
SINGULAIR 75 45 97 201
ENOXAPARIN SODIUM 73 69 98 197
PEN NEEDLE 73 50 98 83
HYDROMORPHONE HCL 70 32 S2 100 174
ESCITALOPRAM OXALATE 70 62 100 164
HUMALOG 70 47 100 188
SANTYL 69 53 103 252
AMOX TR-POTASSIUM CLAVULANATE 69 42 103 113
MORPHINE SULFATE 67 25 S2 105 194
ACTONEL 67 67 105 183
CYMBALTA 67 45 105 109
MELOXICAM 64 44 108 46
KLOR-CON 10 63 44 109 116
GLIMEPIRIDE 63 36 109 58
DOXAZOSIN MESYLATE 63 57 109 111
LACTULOSE 61 58 112 166
LAMOTRIGINE 59 48 113 264
VIMPAT 56 56 114 274
LANTUS SOLOSTAR 56 24 114 71
FENOFIBRATE 56 51 114 43
BENAZEPRIL HCL 54 51 117 49
LOSARTAN-HYDROCHLOROTHIAZIDE 53 33 118 39
FINASTERIDE 53 40 118 54
LYRICA 52 52 120 140
IBUPROFEN 52 39 120 56
TRICOR 51 48 122 141
VENLAFAXINE HCL 51 0 122 173
NYSTATIN 51 48 122 287
ADVAIR DISKUS 51 39 122 52
DIOVAN HCT 50 48 126 151
SAVELLA 50 0 126 290
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.